Please take a moment to review the important CME information on this page.

OCD: Improving Diagnosis, Maximizing Treatment
is no longer available for CME credit.

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Virginia School of Medicine and Public Health and Discovery Health Channel. The University of Virginia School of Medicine and Public Health is accredited by the ACCME to provide continuing medical education for physicians.

The University of Virginia School of Medicine and Public Health designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Program Overview
OCD is one of the most common and debilitating psychiatric disorders affecting more than two million American adults, yet it remains under-diagnosed and under-treated. Discovery Health CME has assembled a panel of experts to help bridge the gap between medical knowledge of OCD and its actual diagnosis and treatment, with emphasis on SSRI therapy.

Learning Objectives
At the conclusion of this program, participants should be able to:

• Review the epidemiology of obsessive-compulsive disorder (OCD).
• Describe the socio-economic consequences of and disability associated with OCD.
• Accurately diagnose OCD, as it compares to other psychiatric disorders.
• Discuss the pathophysiology of OCD and the role of serotonin.
• Discuss the treatment options for OCD, with a particular focus on selective serotonin reuptake inhibitors.

Target Audience
Primary Care Physicians, Psychiatrists, Nurse Practictioners, Physician Assistants, and Other health care professionals

Faculty Disclosure Information
As a sponsor accredited by the ACCME, it is the policy of the University of Virginia School of Medicine to require the disclosure of the existence of any significant financial interest or any other commercial supporter(s) of this activity or the manufacturer(s) of any commercial products(s) discussed in an educational presentation. Detailed disclosure will be made during the program.

Acknowledgement of Commercial Support
This program is funded through an educational grant from Jazz Pharmaceuticals.